• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

KLAS: 87% of Soarian Customers Planning/Considering to Rip & Replace

by HITC Staff 01/25/2016 1 Comment

KLAS Report: Customer Now View Soarian as an Orphaned Product

More than a year ago, Cerner acquired Siemens Health Services, which caused a shift in the marketplace as healthcare IT options would change. In a new KLAS report “Cerner/Siemens Acquisition: Soarian Migration in High Gear,” examines looked the impact the acquisition has had on customers from both companies. The report found that 87% of Siemens’ Soarian Clinicals customers are leaving or planning to leave and find a new EMR system by the end of 2016.

Customers Now View Soarian as an Orphaned Product

KLAS reports that despite Cerner’s promise to continue to develop Soarian Clinicals over the next decade, Soarian customers now view it as an orphaned product. This is largely due to declining customer experience driven by deficient support and a lack of new development —the same problems customers reported before the acquisition.

Some respondents even stated they did not see the need for Cerner to pump wasted dollars into Soarian when they already have highly rated EMR in their portfolio. However, KLAS reports there are a few customers are still hopeful that Cerner will address these gaps.

“My sense is that Cerner will eject Soarian Clinicals as fast as they can figure out how to do it without losing too many people……..The Soarian Clinicals product is just starting to mature and become very formidable, but now we don’t know what will happen. Cerner’s 10-year commitment to Soarian Clinicals doesn’t feel like much,” stated a CIO in the KLAS report.

Prior to the acquisition, Soarian clients moving away from the product moved almost exclusively to Epic. Now, however, many are considering Cerner’s PowerChart system as a strong option.

Revenue Cycle Performance Continues to Lag

Cerner Patient Accounting and Soarian Financials continue to be two of the lowest-performing revenue cycle related products. Despite this, providers using both products are hopeful the acquisition will bring positive change. As it stands, Cerner will need to make significant changes to elevate both solutions to become viable revenue cycle contenders to compete against Epic.

“Cerner’s acquisition of Siemens touches the foundational HIT systems of hundreds of provider organizations and has Soarian customers on an accelerated path to an EMR change,” said Coray Tate, vice president of clinical research at KLAS in a statement. “Patient accounting customers are hoping the vendors’ historically weak financial systems will become stronger together.”

Tagged With: KLAS

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |